Difference between revisions of "Sebaceous carcinoma"

Jump to navigation Jump to search
325 bytes added ,  18:58, 9 November 2021
Line 88: Line 88:


Sebaceous carcinoma versus squamous cell carcinoma:<ref name=pmid26485238>{{cite journal |authors=Plaza JA, Mackinnon A, Carrillo L, Prieto VG, Sangueza M, Suster S |title=Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study |journal=Am J Dermatopathol |volume=37 |issue=11 |pages=809–21 |date=November 2015 |pmid=26485238 |doi=10.1097/DAD.0000000000000255 |url=}}</ref>
Sebaceous carcinoma versus squamous cell carcinoma:<ref name=pmid26485238>{{cite journal |authors=Plaza JA, Mackinnon A, Carrillo L, Prieto VG, Sangueza M, Suster S |title=Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study |journal=Am J Dermatopathol |volume=37 |issue=11 |pages=809–21 |date=November 2015 |pmid=26485238 |doi=10.1097/DAD.0000000000000255 |url=}}</ref>
*CK7, Ber-EP4, EMA.
*CK7 +ve.
 
**Useful if positive: 24 of 27 sebaceous carcinomas +ve; only 2 of 22 squamous cell carcinomas positive.
*Ber-EP4 -ve/+ve.
**Iseful if positive: 7 of 27 sebaceous carcinomas +ve; 0 of 22 squamous cell carcinomas positive.
*EMA +ve.
**Useful if negative: 27 of 27 sebaceous carcinoma positive; 16 of 22 squamous cell carcinoma positive.


Images:
Images:
48,847

edits

Navigation menu